High-dose CHOP plus etoposide (MegaCHOEP) in T-cell lymphoma: a comparative analysis of patients treated within trials of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL)

T-cell lymphomas (T-NHL) generally carry a poor prognosis. High-dose therapy (HDT) and autologous stem cell transplantation (ASCT) are increasingly used to treat younger patients. We treated patients

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Annals of oncology 2009-12, Vol.20 (12), p.1977-1984
Hauptverfasser:	Nickelsen, M., Ziepert, M., Zeynalova, S., Glass, B., Metzner, B., Leithaeuser, M., Mueller-Hermelink, H.K., Pfreundschuh, M., Schmitz, N.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Antineoplastic agents Antineoplastic Combined Chemotherapy Protocols - administration & dosage Antineoplastic Combined Chemotherapy Protocols - therapeutic use autologous transplantation Biological and medical sciences Cyclophosphamide - administration & dosage Cyclophosphamide - therapeutic use Dose-Response Relationship, Drug Doxorubicin - administration & dosage Doxorubicin - therapeutic use Etoposide - administration & dosage Female Hematologic and hematopoietic diseases Humans Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis Lymphoma, T-Cell - drug therapy Male Medical sciences MegaCHOEP Middle Aged Pharmacology. Drug treatments Prednisone - administration & dosage Prednisone - therapeutic use Prognosis T-cell lymphoma Vincristine - administration & dosage Vincristine - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	T-cell lymphomas (T-NHL) generally carry a poor prognosis. High-dose therapy (HDT) and autologous stem cell transplantation (ASCT) are increasingly used to treat younger patients. We treated patients
ISSN:	0923-7534 1569-8041
DOI:	10.1093/annonc/mdp211